PVD News

DIAGNOSTIC AND INTERVENTIONAL CARDIOLOGY (DAIC)

Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions, announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of IVUS in peripheral vascular disease (PVD) interventions. The new consensus and recommendations for use of IVUS aim to improve quality care in PVD and are based on evidence, expert practice standards, and clinical experience.

CARDIOVASCULAR BUSINESS

Patients with peripheral artery disease (PAD) face an above-average risk of death or adverse outcomes when hospitalized for COVID-19, according to a new analysis published in Current Problems in Cardiology. “COVID-19 is a disease with many diverse manifestations, ranging from asymptomatic disease to mild symptoms, and more severely, thrombotic events, acute respiratory syndrome, and death,” wrote lead author Kim G. Smolderen, PhD, a specialist at Yale University, and colleagues.

THE MEDICAL PROGRESS

Bone marrow derived autologous cell therapy (ACT) has been shown to significantly reduce the rate of major amputation at 5 years in people with diabetes who developed critical limb-threatening ischemia (CLTI). In a study of 130 patients, 64% of 42 patients who were treated conservatively needed a major amputation at 5 years versus just 30% of 45 patients who had been treated with ACT (P = .011).

EXPRESS HEALTHCARE

Royal Philips has announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions. The new consensus and recommendations for use of IVUS aim to improve quality care in PVD and are based on evidence, expert practice standards, and clinical experience.

VASCULAR NEWS

A worldwide committee of 40 cross-speciality medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions.

HematologyAdvisor

A systematic review and meta-analysis found that low-dose rivaroxaban with aspirin was more effective than aspirin alone for reducing major cardiovascular (CV) events and limb outcomes among patients with peripheral artery disease (PAD). Findings of the review were recently published in the European Journal of Preventive Cardiology.

THE KOREAN JOURNAL OF PAIN

Background: The effect of lumbar spinal stenosis (LSS) and peripheral vascular disease (PVD), which occurs with similar degenerative conditions, when seen together, has not been studied. The aim of this study is to examine and compare the relationship between pain, balance, disability, fear of falling, and kinesiophobia in LSS patients with intermittent vascular claudication (IVC).

ScienceDaily

Summary: Researchers have shown that high levels of a specific protein circulating in the blood accurately detect a severe type of peripheral artery disease that narrows the arteries in the legs and can raise the risk of heart attack and stroke.

DOVEPRESS

Purpose: Sleep duration was associated with large artery atherosclerosis, but its association with atherosclerosis in lower extremity arteries was not well studied. Together with sleep, physical activity constitutes main component of our daily life and influences sleep. Here, we aimed to examine the independent and joint associations of sleep duration and physical activity with peripheral artery disease (PAD) in Chinese adults.

DIABETES NEWS JOURNAL

African-American people are at higher risk for diabetes and peripheral arterial disease (PAD), which combined make them more susceptible to preventable amputations. African-Americans are, statistically, twice as likely as non-Hispanic whites to have PAD. At the same time, one in four older African-American has diabetes.